Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in Humans
Open Access
- 5 March 2009
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (6) , 2906-2914
Abstract
Although ovarian nerve growth factor (NGF) facilitates follicular development and ovulation, an excess of the neurotrophin in the rodent ovary reduces ovulatory capacity and causes development of precystic follicles. Here we show that ovarian NGF production is enhanced in patients with polycystic ovarian syndrome (PCOS) and that transgenically driven overproduction of NGF targeted to the ovary results in cystic morphology, when accompanied by elevated LH levels. NGF levels are increased in the follicular fluid from PCOS ovaries and in the culture medium of granulosa cells from PCOS patients, as compared with non-PCOS patients. Ovaries from transgenic mice carrying the NGF gene targeted to thecal-interstitial cells by the 17α-hydroxylase gene promoter produce more NGF than wild-type (WT) ovaries and are hyperinnervated by sympathetic nerves. Antral follicle growth is arrested resulting in accumulation of intermediate size follicles, many of which are apoptotic. Peripubertal transgenic mice respond to a gonadotropin challenge with a greater increase in plasma 17-hydroxyprogesterone, estradiol, and testosterone levels than WT controls. Transgenic mice also exhibit a reduced ovulatory response, delayed puberty, and reduced fertility, as assessed by a prolonged interval between litters, and a reduced number of pups per litter. Sustained, but mild, elevation of plasma LH levels results in a heightened incidence of ovarian follicular cysts in transgenic mice as compared with WT controls. These results suggest that overproduction of ovarian NGF is a component of polycystic ovarian morphology in both humans and rodents and that a persistent elevation in plasma LH levels is required for the morphological abnormalities to appear.Keywords
This publication has 45 references indexed in Scilit:
- Increased Androgen Response to Follicle-Stimulating Hormone Administration in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008
- Deletion of theTtf1Gene in Differentiated Neurons Disrupts Female Reproduction without Impairing Basal Ganglia FunctionJournal of Neuroscience, 2006
- Identification of Op18/stathmin as a potential target of ASK1‐p38 MAP kinase cascadeJournal of Cellular Physiology, 2005
- Voltage-dependent K+channel acts as sex steroid sensor in endocrine cells of the human ovaryJournal of Cellular Physiology, 2005
- Regulation of Gonadotropin Secretion: Implications for Polycystic Ovary SyndromeSeminars in Reproductive Medicine, 2002
- Current Concepts in the Polycystic Ovary SyndromeAnnual Review of Medicine, 2001
- Tumor Necrosis Factor-induced Microtubule Stabilization Mediated by Hyperphosphorylated Oncoprotein 18 Promotes Cell DeathJournal of Biological Chemistry, 2000
- Treatment of Polycystic Ovary Syndrome: An OverviewHormone Research, 1990
- The Nerve Growth Factor 35 Years LaterScience, 1987
- Polycystic-Ovary Syndrome — What Is It?New England Journal of Medicine, 1983